FindTrial
Sign In

To explore the pathogenic features of pulmonary infection and establish a prognostic model in immunodeficiency and immunocompetent patients

To explore the pathogenic features of pulmonary infection and establish a prognostic model in immunodeficiency and immunocompetent patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057821
Enrollment
Unknown
Registered
2022-03-18
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary infection

Interventions

None listed

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Able to provide written informed consent (ICF), understand and agree to abide by the research requirements and evaluation schedule; 2. Age > 18 years old, diagnosed with pneumonia (lung infection).

Exclusion criteria

Exclusion criteria: 1. Patients with bronchiectasis; 2. Patients with active tuberculosis; 3. Patients with obstructive pneumonia; 4. Patients who cannot understand and implement the study plan.

Design outcomes

Secondary

MeasureTime frame
Antigen of streptococcus pneumoniae;Antigen of legionella pneumophila;Count of T cell;Blood routine examination;Biochemical detection;C-reactive protein;ESR;PCT;—

Primary

MeasureTime frame
Etiology;—

Countries

China

Contacts

Public ContactHong Fan

West China Hospital of Sichuan University

fanhongfan@qq.com+86 18980601659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026